Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation

BACKGROUND: High intensity treatments such as hematopoietic cell transplantation (HCT) can be curative for patients with hematologic malignancies, but this needs to be balanced by the high risk of nonrelapse mortality (NRM) during the first 2 years after HCT. Sarcopenia (low muscle mass) is associat...

Full description

Saved in:
Bibliographic Details
Published in:J Natl Cancer Inst
Main Authors: Armenian, Saro H, Xiao, Meisi, Berano Teh, Jennifer, Lee, Brandyn, Chang, Howard A, Mascarenhas, Kristen, Lee, Sean, Iukuridze, Alex, Xie, Jack J, Scott, Jessica M, Jones, Lee W, Lennie Wong, F, Forman, Stephen J, Nakamura, Ryotaro
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6695315/
https://ncbi.nlm.nih.gov/pubmed/30951603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy231
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items